Effects of interleukin-1 receptor antagonist on lymphocyte and macrophage of rats with collagen-induced arthritis
Wei Wei
Abstract
Wei Wei
Abstract
Objective:To investigate protections of interleukin-1 receptor antagonist (IL-lra) against collagen-induced arthritis (CIA) in rats. Methods: A CIA model was set up in SD rats by subcutaneous injection with type II collagen. The severity of arthritis was rated with arthritis scores. The examination of conA-and lipid polysaccharide (LPS)-induced splenocytes proliferation and interleukin-1 (IL-1) activities were conducted using a 3H-TdR intake method. Tumor necrosis factor alpha (TNF-α) and PGE_2 in the culture broth of macrophage (PMΦ) were quantified using radioimmunoassay. Results: The conA or LPS increased the level of T-and B-lymphocyte in 10 days after CIA in rats. The local inflammatory symptoms and B lymphocytes proliferation were reduced after subcutaneous injection with IL-lra at 7.5,30 and 120mg·kg~(-1)·d for 7 days, and T lymphocyte proliferation was suppressed when IL-lra at 30 and 120mg·kg~(-1)·d~(-1) was s. c. given in rats with CIA. The IL-1, TNF-α and PGR_2 levels in the PMΦ were inhibited by IL-1ra. Conclusion: IL-1ra inhibits the proliferation of lymphocytes and macrophage in the CIA rats.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate protections of interleukin-1 receptor antagonist (IL-lra) against collagen-induced arthritis (CIA) in rats. Methods: A CIA model was set up in SD rats by subcutaneous injection with type II collagen. The severity of arthritis was rated with arthritis scores. The examination of conA-and lipid polysaccharide (LPS)-induced splenocytes proliferation and interleukin-1 (IL-1) activities were conducted using a 3H-TdR intake method. Tumor necrosis factor alpha (TNF-α) and PGE_2 in the culture broth of macrophage (PMΦ) were quantified using radioimmunoassay. Results: The conA or LPS increased the level of T-and B-lymphocyte in 10 days after CIA in rats. The local inflammatory symptoms and B lymphocytes proliferation were reduced after subcutaneous injection with IL-lra at 7.5,30 and 120mg·kg~(-1)·d for 7 days, and T lymphocyte proliferation was suppressed when IL-lra at 30 and 120mg·kg~(-1)·d~(-1) was s. c. given in rats with CIA. The IL-1, TNF-α and PGR_2 levels in the PMΦ were inhibited by IL-1ra. Conclusion: IL-1ra inhibits the proliferation of lymphocytes and macrophage in the CIA rats.
Key concepts: Arthritis, Endocrinology, Internal medicine, Tumor necrosis factor alpha, Splenocyte, Interleukin 1 receptor antagonist, Interleukin 2, Interleukin